-+ 0.00%
-+ 0.00%
-+ 0.00%

Arecor Therapeutics Obtains Patents in Europe, US, India, for Rapid-acting Insulin

MT Newswires·10/15/2026 06:40:58
Listen to the news
06:40 AM EDT, 10/15/2026 (MT Newswires) -- Arecor Therapeutics (AREC.L) secured new patents in Europe, the US and India for its concentrated and rapid-acting insulin, AT278. The clinical-stage biotechnology company said Thursday that the European Patent Office and the US Patent and Trademark Office issued separate patents for the use of the proprietary product in automated insulin delivery systems, while the Indian Patent Office issued a fresh protection for the novel composition of AT278.